Changes in signal-to-noise ratios and contrast-to-noise ratios of hypervascular hepatocellular carcinomas on ferucarbotran-enhanced dynamic MR imaging

European Journal of Radiology

Volumn 59, Issue 3, 2006, Pages 424-431

  Park, Yulri ^a   Choi, Dongil ^a   Kim, Seong Hyun ^a   Kim, Seung Hoon ^a   Kim, Min Ju ^a   Lee, Jongmee ^a   Lim, Jae Hoon ^a   Lee, Won Jae ^a   Lim, Hyo K ^a  

^a Samsung Medical Center   (South Korea)

Author keywords

Contrast to noise ratio; Dynamic MR imaging; Ferucarbotran; Hepatocellular carcinomas; Signal to noise ratio; Superparamagnetic iron oxide

Indexed keywords

CONTRAST-TO-NOISE RATIO; DYNAMIC MR IMAGING; FERUCARBOTRANS; HEPATOCELLULAR CARCINOMAS; SUPERPARAMAGNETIC IRON OXIDES;

MAGNETIC RESONANCE IMAGING; MATERIALS SCIENCE; PATIENT TREATMENT; SIGNAL TO NOISE RATIO;

TUMORS;

SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CALCULATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL NOISE RATIO;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DEXTRANS; FEMALE; FERROSOFERRIC OXIDE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; IRON; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OXIDES;

EID: 33748078779     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2006.06.018     Document Type: Article

References (24)

1. Baron R.L., Oliver III J.H., Dodd III G.D., Nalesnik M., Holbert B.L., and Carr B. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. Radiology 199 (1996) 505-511
2. Oi H., Murakami T., Kim T., Matsushita M., Kishimoto H., and Nakamura H. Dynamic MR imaging and early-phase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma. Am J Roentgenol 166 (1996) 369-374
3. Yamashita Y., Mitsuzaki K., Yi T., et al. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 200 (1996) 79-84
4. Mitsuzaki K., Yamashita Y., Ogata I., Nishiharu T., Urata J., and Takahashi M. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing. Am J Roentgenol 167 (1996) 753-757
5. Baron R.L. Understanding and optimizing use of contrast material for CT of the liver. Am J Roentgenol 163 (1994) 323-331
6. Peterson M.S., Baron R.L., and Murakami T. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging. Radiology 201 (1996) 337-345
7. Tang Y., Yamashita Y., Namimoto T., Abe Y., and Takahashi M. Liver T2-weighted MR imaging: comparison of fast and conventional half-Fourier single-shot turbo spin-echo, breath-hold turbo spin-echo, and respiratory-triggered turbo spin-echo sequences. Radiology 203 (1997) 766-772
8. Tanaka M., Nakashima O., Wada Y., Kage M., and Kojiro M. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 24 (1996) 807-812
9. Vogl T.J., Hammerstingl R., Schwarz W., et al. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 198 (1996) 881-887
10. Tang Y., Yamashita Y., Arakawa A., et al. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. Am J Roentgenol 172 (1999) 1547-1554
11. Choi D., Kim S.H., Lim J.H., et al. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus combined helical CT during arterial portography and CT hepatic arteriography. Am J Roentgenol 176 (2001) 475-482
12. Pauleit D., Textor J., Bachmann R., et al. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver. Radiology 222 (2002) 73-80
13. Kang B.K., Lim J.H., Kim S.H., et al. Preoperative depiction of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus triple-phase helical CT. Radiology 226 (2003) 79-85
14. Jung C.W., and Jacobs P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 13 (1995) 661-674
15. Vogl T.J., Hammerstingl R., Schwarz W., et al. Magnetic resonance imaging of focal liver lesions: comparison of the superparamagnetic iron oxide Resovist versus gadolinium-DTPA in the same patient. Invest Radiol 31 (1996) 696-708
16. Reimer P., Muller M., Marx C., et al. T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration-preliminary clinical experience with dynamic T1-weighted MR imaging. Radiology 209 (1998) 831-836
17. Lutz A.M., Willmann J.K., Goepfert K., Marincek B., and Weishaupt D. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Radiology 237 (2005) 520-528
18. Lim J.H., Choi D., Cho S.K., et al. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 220 (2001) 669-676
19. Tanimoto A., Yuasa Y., Shinmoto H., et al. Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function. Radiology 222 (2002) 661-666
20. Hamm B., Staks T., Taupitz M., et al. Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide. J Magn Reson Imaging 4 (1994) 659-668
21. Matsuo M., Kanematsu M., Itoh K., et al. Detection of malignant hepatic tumors: comparison of gadolinium- and ferumoxide-enhanced MR imaging. Am J Roentgenol 177 (2001) 637-643
22. Reimer P., and Tombach B. Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur Radiol 8 (1998) 1198-1204
23. Harisinghani M.G., Saini S., Weissleder R., et al. Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227. Radiology 202 (1997) 687-691
24. Kumano S., Murakami T., Kim T., et al. Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions. Am J Roentgenol 181 (2003) 1335-1339